COLO-RECTAL CANCER (DMMR/MSI-H CRC)
Clinical trials for COLO-RECTAL CANCER (DMMR/MSI-H CRC) explained in plain language.
Never miss a new study
Get alerted when new COLO-RECTAL CANCER (DMMR/MSI-H CRC) trials appear
Sign up with your email to follow new studies for COLO-RECTAL CANCER (DMMR/MSI-H CRC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope: immune drug before surgery for tough colorectal cancer
Disease control Recruiting nowThis study looks at whether giving the drug tislelizumab before surgery can help people with a certain type of colorectal cancer (dMMR/MSI-H). About 30 adults with stage II or III cancer will get three doses of the drug, then have surgery. Researchers will check if the cancer dis…
Matched conditions: COLO-RECTAL CANCER (DMMR/MSI-H CRC)
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 12, 2026 12:05 UTC
-
Cancer patients choose: quick shot or long IV?
Symptom relief Recruiting nowThis study looks at whether people with certain cancers prefer getting their immune therapy as a shot under the skin (subcutaneous) or through a needle in a vein (intravenous). About 880 adults who are already eligible for standard treatments like nivolumab or pembrolizumab will …
Matched conditions: COLO-RECTAL CANCER (DMMR/MSI-H CRC)
Phase: PHASE2 • Sponsor: Diwakar Davar • Aim: Symptom relief
Last updated Jun 22, 2026 12:01 UTC